3Evans, J D. Ghaneh, P Kawesha A. et al. Role of matrix metalloproteinases and their inhibitors in pancreatic cancer[J]. Digestion, 1997.58(6) : 520- 528.
4Warshaw A L, Fernandez-del Castillo C. Pancreatic carcinoma . N Engl J Med,1992,326(7) :455--465.
5Singh S M. Longmire W P J, Reber H A. Surgical palliation for pancreatic cancer. The UCLA experience . Ann Surg, 1990,212 (2) : 132-- 139.
6Oettle H, Arnold D, Riess H. Adjuvant therapy of pancreatic carcinoma Schweiz Rundsch Med Prax(rerman),2000,89(48):2017-2025.
7Storniolo A M,Enas N H,Brown C A.An investigational new drug treatment program for patients with gemcitabine:results for over 3 000 patients with pancreatic carcinoma . Cancer. 1999,85(6) :1261--1268.
8Poen J C,Ford J M,Niederhuber J E.Chemoradiotherapy in the management of localized tumors of the pancreas .Ann Sur Oncot,1999.6(1):117-122.
9Killion J. Radiusky R 1, Fidler J, Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev, 1999, 17(3) :279-284.
10Harrison L E, Wojciechowicz D C, Brennanet al M F. Phenylacetate inbibits isoprenoid biosynthesis and suppresses growth of human pancreatic carcinoma[J]. Surgery, 1998.124(3) : 541 --550.
